Overview Request Sample Pages Request Customization Download PDF
You are viewing: Australia Veterinary Vaccines Market analysis
Part of: Veterinary Vaccines Market (Global)

The Australia Veterinary Vaccines Market was valued at $79.45 Million in 2024 and projected to reach to $107.07 Million by 2029, representing a compound annual growth rate of 6.1%. Australia's veterinary vaccines market is positioned for steady expansion through 2029, driven by increasing awareness of animal health management and biosecurity protocols.

Australia Veterinary Vaccines Market Trends and Insights

  • This growth trajectory reflects Australia's strong commitment to animal health and biosecurity standards, driven by the country's significant livestock and companion animal populations.
  • Australia's market expansion is supported by increasing awareness of preventive healthcare for pets and livestock, stringent regulatory frameworks, and rising investment in veterinary infrastructure across the nation. The Australian veterinary vaccines sector benefits from robust demand across both companion animal and production animal segments.
  • Australia's geographic isolation and strict quarantine protocols have historically emphasized vaccination as a critical disease prevention tool, reinforcing market adoption.
  • Between 2024 and 2029, Australia is expected to see accelerated growth driven by technological advancements in vaccine formulations, expanding rural veterinary services, and growing pet ownership trends in urban centers.
  • The market's 6.1% compound annual growth rate reflects Australia's position as a developed economy with high standards for animal welfare and disease management..

Key Market Statistics

  • CAGR (2024-2029) : 6.1% CAGR
  • Market Size, 2024 : ~USD 79.45
  • Forecast, 2029 : ~USD 107.07
  • Country : Australia

Australia Veterinary Vaccines Market Overview

Market Valuation :

Australia's veterinary vaccines market is valued at USD 79.45 million in 2024, with a projected CAGR of 6.1% through 2029, reaching USD 107.07 million by forecast end.

Biosecurity Leadership :

Australia's stringent biosecurity regulations and disease-free status drive consistent demand for preventive veterinary vaccines across livestock and companion animal sectors.

Livestock & Companion Animal Base :

The market is supported by Australia's substantial sheep, cattle, and companion animal populations, creating sustained demand for comprehensive vaccination programs.

Regulatory Environment :

Australia's strict animal health standards and import/export requirements create a robust market for high-quality veterinary vaccines and preventive health solutions.

Australia Veterinary Vaccines Market Dynamics

  • The country's export-oriented agricultural sector necessitates rigorous vaccination standards to maintain disease-free status and market access.
  • Growing pet ownership and rising consumer spending on companion animal healthcare further support market growth.
  • Investment in veterinary infrastructure and adoption of advanced vaccination technologies will enhance market penetration across rural and urban regions..

Related Ecosystem

Animal Health

Top Technologies
  • Polymerase Chain Reaction (PCR) Tests
  • Porcine
  • Immunodiagnostics
  • Lateral Flow Assays
  • Microarrays
Top Companies
  • Zoetis Inc.
  • Patterson Companies, Inc.
  • Virbac
  • Elanco Animal Health Incorporated
  • BOEHRINGER INGELHEIM GMBH

    Pharmaceuticals

    Top Technologies
    • Bioreactors
    • Analytical Testing
    • Bioanalytical Testing Services
    • Cell Counters
    • Data Management Services
    Top Companies
    • Merck KGaA
    • Thermo Fisher Scientific Inc.
    • SANOFI
    • NOVARTIS
    • Pfizer Inc.

      Key Takeaways

      • Australia's veterinary vaccines market is valued at USD 79.45 million in 2024 and is forecast to reach USD 107.07 million by 2029, representing a 6.1% CAGR.
      • Australia's strict biosecurity regulations and geographic isolation drive strong demand for preventive vaccination across livestock and companion animal segments.
      • Growing pet ownership in Australian urban centers and expanding rural veterinary infrastructure are key growth catalysts for the market through 2029.
      • Australia's developed healthcare standards and investment in animal welfare position the country as a mature, high-value veterinary vaccines market within Asia Pacific.

      Australia Veterinary Vaccines Market Report Scope

      Report Metric Details
      Base Year 2024
      Fastest Growing Segment CHINA (Disease)
      Forecast Period 2024–2029
      Growth Rate CAGR of 6.1% from 2024 to 2029
      Largest Segment VETERINARY HOSPITALS (End User)
      Market Size Base Year 9.91 (2024)
      Revenue Forecast 13.33 (2029)
      Segments Covered Type, Disease, Technology, Route Of Administration, End User

      Australia Veterinary Vaccines Market Report Segmentation

      5 segment dimensions are covered across the global market.

      By Type

      • Aquaculture Vaccines
      • Bovine Diseases
      • Bovine Vaccines
      • Canine Diseases
      • Canine Vaccines
      • Companion Animal Vaccines
      • Feline Diseases
      • Feline Vaccines
      • Livestock Vaccines
      • Other Veterinary Vaccines
      • Porcine Vaccines
      • Poultry Vaccines
      • Small Ruminant Diseases
      • Small Ruminant Vaccines

      By Disease

      • Aquaculture Diseases
      • Companion Animal Diseases
      • Livestock Diseases
      • Other Veterinary Diseases
      • Porcine Diseases
      • Poultry Diseases

      By Technology

      • Inactivated Vaccines
      • Live Attenuated Vaccines
      • Other Vaccine Technologies
      • Recombinant Vaccines
      • Toxoid Vaccines

      By Route Of Administration

      • Intramuscular
      • Intramuscular Route Of Administration
      • Intranasal/Spray
      • Intranasal/Spray Route Of Administration
      • Intraocular
      • Intraocular Route Of Administration
      • Oral
      • Oral Route Of Administration
      • Other Routes Of Administration
      • Subcutaneous
      • Subcutaneous Route Of Administration

      By End User

      • Other End Users
      • Veterinary Clinics
      • Veterinary Hospitals

      Target Audience

      • Veterinary Pharmaceutical Companies : Manufacturers and distributors need Australia-specific market data to optimize product portfolios, pricing strategies, and distribution networks for the growing veterinary vaccine segment.
      • Livestock & Agricultural Producers : Farmers and agricultural enterprises require market intelligence on vaccine availability, efficacy trends, and biosecurity compliance to protect herd health and export eligibility.
      • Veterinary Clinics & Hospitals : Practice owners and veterinarians need market forecasts and product trend data to stock appropriate vaccines, plan inventory, and advise clients on preventive health protocols.
      • Investment & Private Equity Firms : Investors evaluating opportunities in Australia's animal health sector require validated market sizing, growth projections, and competitive landscape analysis for due diligence.
      • Government & Regulatory Bodies : Agricultural and health authorities need market data to inform biosecurity policies, disease prevention strategies, and resource allocation for animal health programs.

      Key Companies in the Australia Veterinary Vaccines Market

      CompanyHQOwnershipStrongest segments
      KBNP,INC.South KoreaPrivate CompanyPoultry and swine medicines,Cattle and aquaculture products,Companion animal medicines,
      KOMIPHARM INTERNATIONALSouth KoreaPublic CompanyVeterinary vaccines,Veterinary pharmaceuticals (injectable, oral, topical),Disinfectants and bio-fertilizers,
      BAYER AGGermanyPublic CompanyCrop Science,Pharmaceuticals,Consumer Health,
      HESKA CORPORATIONUnited StatesPrivate CompanyIn-clinic analyzers (chemistry, hematology, blood gas, coagulation, immunodiagnostics),Imaging and informatics (digital radiography, mobile DR, ultrasound, Cloudbank, telecytology),Point-of-care infectious disease tests and allergy products/services,
      QUIMTIA S.A.BrazilPrivate CompanyPoultry feed and premix,Swine feed and premix,Bovine and ruminant nutrition,
      TEREOSFrancePrivate CompanySugar and sweetening ingredients (including organic cane and beet sugar),Starches and derivatives (food, industrial, bioplastics, corrugated cardboard),Alcohol and ethanol (food, industrial, fuel, and pharma uses),
      SANOFIFrancePublic CompanyPediatric and combination vaccines (polio, pertussis, Hib, hexavalent),Other vaccines (RSV, hepatitis A, typhoid, yellow fever, rabies),Immunology and inflammation therapies,
      PATTERSON COMPANIES, INCUnited StatesPrivate CompanyDental consumables and equipment,Dental software and practice optimization,Animal health products and private label,
      MERCK & CO., INC.United StatesPublic CompanyOncology (Keytruda, Keytruda Qlex, Welireg, ADC collaborations),Vaccines (Gardasil, pediatric, pneumococcal, rotavirus),Cardiometabolic, infectious disease, and other human pharma,
      ZOETISUnited StatesPublic CompanyParasiticides,Vaccines,Dermatology,
      ELANCOUnited StatesPublic CompanyCompanion animal parasiticides (Seresto, K-9 Advantage, Advantix, Advocate, Credelio, Interceptor Plus, Drontal),Companion animal vaccines and therapeutics (Galliprant, Atopica, Onsior, Tru Family, cardiovascular and dermatology),Farm animal feed additives and antibiotics (Rumensin, Experior, Baytril, Denagard, Pulmotil, Surmax, Hemicell),
      CEVAUnited StatesPublic Company5G/5G-Advanced baseband DSP and RAN IP (PentaG-RAN, Ceva XC20/XC21/XC23, PentaG2, Ceva-BX2),Connectivity IP (Ceva-Waves Bluetooth, Wi-Fi, UWB, Links, DragonFly NB-IoT),Sensing, audio, and sensor-fusion IP (Ceva-SensPro, Ceva-BX1, ClearVox, RealSpace, MotionEngine),
      VIRBACFrancePublic CompanyCompanion animal parasiticides (e.g., Prevexto),Companion animal specialty therapeutics (dermatology, stress, mobility, kidney, dental),Companion animal vaccines and antibiotics,
      PHIBRO ANIMAL HEALTH CORPORATIONUnited StatesPublic CompanyAnimal Health (antibacterials, anticoccidials, nutritional specialties, vaccines, adjuvants, microbial and bioproducts),Mineral Nutrition (trace mineral formulations and concentrations),Performance Products (specialty ingredients for personal care, industrial chemicals, catalysts),
      HESTER BIOSCIENCES LIMITEDIndiaPublic CompanyPoultry vaccines,Large-animal vaccines (cattle, small ruminants),Companion animal and specialty biologics,
      NEOGEN CORPORATIONUnited StatesPublic CompanyFood Safety diagnostics, media, and sanitation,Animal Safety reagents, instruments, and animal care products,Genomics services for livestock and companion animals,
      TIANJIN RINGPU BIO-TECHNOLOGY CO., LTD.ChinaPublic CompanyVeterinary vaccines,Chemical drugs and APIs,Feed and functional additives,
      CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD.ChinaPublic CompanyAnimal Disease Epidemic Prevention (vaccines and biologicals),Animal Disease Treatment (veterinary chemical products),Animal Nutrition (feed, premixes, additives, raw material trade),
      JINYU BIO-TECHNOLOGY CO., LTD.ChinaPublic CompanyPorcine vaccines (PRRS, pseudorabies, FMD, circovirus, swine fever, influenza, TGE),Poultry vaccines (avian influenza, Newcastle disease, IBD, IB, egg drop syndrome),Ruminant and brucellosis vaccines,

      KBNP,INC.

      KBNP,INC. is a private company based in South Korea with 96 employees, founded in 1988.

      KOMIPHARM INTERNATIONAL

      KOMIPHARM INTERNATIONAL is a public company based in South Korea with 161 employees, established in 1972.

      BAYER AG

      Bayer AG is a public company based in Germany with 87,757 employees, founded in 1863.

      HESKA CORPORATION

      HESKA CORPORATION is a private company based in the United States with 808 employees, founded in 1988.

      QUIMTIA S.A.

      QUIMTIA S.A. is a private company based in Brazil, established in 1975.

      TEREOS

      TEREOS is a private company based in France with 10,241 employees, founded in 1996.

      SANOFI

      Sanofi is a public company based in France with 74,846 employees, established in 1994.

      PATTERSON COMPANIES, INC

      PATTERSON COMPANIES, INC is a private company based in the United States with 7,600 employees, founded in 1877.

      MERCK & CO., INC.

      Merck & Co., Inc. is a public company based in the United States with 74,000 employees, established in 1891.

      ZOETIS

      Zoetis is a public company based in the United States with 14,500 employees, founded in 2012.

      ELANCO

      Elanco is a public company based in the United States with 9,650 employees, founded in 1954.

      CEVA

      Ceva is a public company based in the United States with 400 employees, established in 1999.

      VIRBAC

      Virbac is a public company based in France with 6,442 employees, founded in 1968.

      PHIBRO ANIMAL HEALTH CORPORATION

      Phibro Animal Health Corporation is a public company based in the United States with 2,475 employees, established in 1946.

      HESTER BIOSCIENCES LIMITED

      HESTER BIOSCIENCES LIMITED is a public company based in India, founded in 1987.

      NEOGEN CORPORATION

      Neogen Corporation is a public company based in the United States with 2,974 employees, established in 1981.

      TIANJIN RINGPU BIO-TECHNOLOGY CO., LTD.

      TIANJIN RINGPU BIO-TECHNOLOGY CO., LTD. is a public company based in China with 2,803 employees, founded in 1998.

      CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD.

      CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD. is a public company based in China with 3,996 employees, established in 1998.

      JINYU BIO-TECHNOLOGY CO., LTD.

      JINYU BIO-TECHNOLOGY CO., LTD. is a public company based in China with 1,881 employees, founded in 1992.

      Reasons to Buy this Report

      • Market Size & Growth Data : Access precise valuation metrics for Australia's veterinary vaccines market with verified 2024 baseline (USD 79.45M) and 2029 forecasts, enabling accurate business planning and investment decisions.
      • Biosecurity & Regulatory Insights : Understand Australia's unique biosecurity requirements and regulatory landscape that drive vaccine demand, helping suppliers align products with local compliance standards.
      • Segment Performance Analysis : Identify growth opportunities across livestock and companion animal vaccine segments specific to Australia's market structure and consumer preferences.
      • Competitive Positioning : Benchmark your organization against market trends and competitor strategies tailored to Australia's veterinary healthcare ecosystem and distribution channels.
      • Strategic Market Entry : Develop informed market entry or expansion strategies with country-specific insights on demand drivers, customer segments, and growth catalysts through 2029.

      Frequently asked questions

      What is the current size of Australia's veterinary vaccines market?

      Australia's veterinary vaccines market was valued at USD 79.45 million in 2024 and is projected to grow to USD 107.07 million by 2029.

      What is the expected growth rate for Australia's veterinary vaccines market?

      Australia's veterinary vaccines market is expected to grow at a compound annual growth rate (CAGR) of 6.1% from 2024 to 2029.

      What factors are driving growth in Australia's veterinary vaccines market?

      Key drivers include Australia's strict biosecurity standards, rising pet ownership, expanding rural veterinary services, technological advances in vaccine formulations, and strong emphasis on preventive animal healthcare.

      Which segments contribute most to Australia's veterinary vaccines market?

      Australia's market is driven by both companion animal vaccines (pets) and production animal vaccines (livestock), with strong demand across both segments due to regulatory requirements and animal welfare standards.

      How does Australia's market compare to the broader Asia Pacific region?

      Australia represents a mature, high-value segment within the Asia Pacific veterinary vaccines market, characterized by developed healthcare infrastructure, stringent regulatory frameworks, and high per-capita spending on animal health.

      RESEARCH METHODOLOGY

      This study involved the extensive use of both primary and secondary sources. The research process involved examining various factors affecting the industry to identify segmentation types, industry trends, key players, the competitive landscape, fundamental market dynamics, and key players' strategies.

      Secondary Research

      The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, SEC filings of companies and publications from government sources such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), American Veterinary Medical Association (AVMA), Animal Health Institute (AHI), National Animal Health Laboratory Network (NAHLN), and Food and Agriculture Organization of the United Nations (FAO) were referred to identify and collect information for the global veterinary vaccines market study. It was also used to obtain important information about key players, market classification & segmentation according to industry trends, down to the bottom-most level, and key developments from market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

      Primary Research

      In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and other key executives from various companies and organizations in the veterinary vaccines market. The primary sources from the demand side include hospitals & clinics, physiotherapy clinics, and home care settings. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.

      A breakdown of the primary respondents is provided below:

      Veterinary Vaccines Market

      *C-level primaries include CEOs, CFOs, COOs, and VPs.

      *Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

      Note: Companies are classified into tiers based on their total revenue. As of 2025, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.

      Source: MarketsandMarkets Analysis

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      For the global market value, annual revenues were calculated using revenue mappings of major product manufacturers and OEMs active in the global veterinary vaccines market. All the major product manufacturers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/sub-segments was done for the major players (who contribute at least 70-75% of the market share at the global level). Also, the global veterinary vaccines   market was split into various segments and sub-segments based on:

      • List of major players operating in the veterinary vaccines   products market at the regional and/or country level
      • Product mapping of various veterinary vaccine manufacturers at the regional and/or country level
      • Mapping of annual revenue generated by listed major players from veterinary vaccines (or the nearest reported business unit/product category)
      • Revenue mapping of major players to cover at least 70-75% of the global market share as of 2025
      • Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
      • Summation of the market value of all segments/subsegments to arrive at the global point-of-care  diagnostics market

      The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

      Market Size Estimation (Bottom Up approach & Top down approach)

      Veterinary Vaccines Market

      Data Triangulation

      After determining the overall size of the global veterinary vaccines market using the above-mentioned methodology, the market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed, where applicable, to complete the overall market engineering process and derive the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both demand- and supply-side participants.

      Market Definition

      A veterinary vaccine is a biological preparation that provides immunity by stimulating an animal’s immune system to recognize and combat a specific pathogen. The veterinary vaccines market includes live attenuated, inactivated, recombinant, and toxoid vaccines for a wide range of animals, including poultry, livestock, porcine, aquaculture, and companion animals. Vaccination improves animal health, reduces the incidence of zoonotic diseases, supports higher productivity, and helps secure economic stability.   

      Stakeholders

      • Animal vaccine manufacturers
      • Animal healthcare product manufacturers
      • Animal vaccine distributors and wholesalers
      • Animal welfare associations
      • Veterinary clinics and care centers
      • Research and consulting firms
      • Veterinary Research and Development Organizations 
      • Contract research organizations
      • Contract manufacturing organizations
      • Venture capitalists

      Report Objectives

      • To define, measure, and describe the global veterinary vaccines  market by type, disease, technology, route of administration, and end user
      • To provide detailed information about the major factors influencing the market growth (drivers, restraints, challenges, and opportunities)
      • To strategically analyze the regulatory scenario, pricing, value chain analysis, supply chain analysis, ecosystem analysis, technology analysis, Porter’s Five Forces analysis, pipeline analysis, and patent analysis
      • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
      • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
      • To forecast the size of market segments in North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
      • To strategically analyze the market structure, profile the key players in the global veterinary vaccines  market, and comprehensively analyze their core competencies
      • To track and analyze company developments such as acquisitions, partnerships, expansions, and product launches and approvals in the veterinary vaccines  market

      Available Customizations

      With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:

      GEOGRAPHIC ANALYSIS

      • Further breakdown of the Rest of Europe veterinary vaccines market into Russia, Switzerland, Denmark, Austria, and others
      • Further breakdown of the Rest of Asia Pacific veterinary vaccines  market into Taiwan and others
      • Further breakdown of the Rest of Latin America veterinary vaccines  market into Argentina, Colombia, Chile, Ecuador, and others
      • Further breakdown of the Southeast Asia veterinary vaccines market into Malaysia, Singapore, Australia, and others  

      COMPETITIVE LANDSCAPE ASSESSMENT

      • Market share analysis, by region (North America and Europe), which provides market shares of the top 3-5 key players in the veterinary vaccines  market
      • Competitive leadership mapping for established players in the US  

       

      Get the Full Veterinary Vaccines Market Report

      Full forecast, segment splits, and company analysis for all Veterinary Vaccines Market.

      Download Sample Pages Buy Report

      METHODOLOGY

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      Cite this Research
      DMCA.com Protection Status